Huang Jiaxi, Zhang Jiaqi, Zhang Tingyu, Wang Pu, Zheng Zhong
Mental Health Center, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Front Psychiatry. 2022 Apr 4;13:876136. doi: 10.3389/fpsyt.2022.876136. eCollection 2022.
Previous studies have shown the clinical effect of 2 Hz repetitive transcranial magnetic stimulation (rTMS) for depression; however, its underlying neural mechanisms are poorly understood. The aim of this study was to examine the effects of rTMS on the activity of the prefrontal cortex in patients with depression, using functional near-infrared spectroscopy (fNIRS).
Forty patients with major depressive disorder (MDD) and 40 healthy controls were enrolled in this study. Patients underwent 4 weeks of 2 Hz TMS delivered to the right dorsolateral prefrontal cortex (DLPFC). fNIRS was used to measure the changes in the concentration of oxygenated hemoglobin ([oxy-Hb]) in the prefrontal cortex during a verbal fluency task (VFT) in depressed patients before and after rTMS treatment. The severity of depression was assessed using the Hamilton Rating Scale for Depression-24 item (HAMD-24).
Prior to rTMS, depressed patients exhibited significantly smaller [oxy-Hb] values in the bilateral prefrontal cortex during the VFT compared with the healthy controls. After 4 weeks of 2 Hz right DLPFC rTMS treatment, increased [oxy-Hb] values in the bilateral frontopolar prefrontal cortex (FPPFC), ventrolateral prefrontal cortex (VLPFC) and left DLPFC during the VFT were observed in depressed patients. The increased [oxy-Hb] values from baseline to post-treatment in the right VLPFC in depressed patients were positively related to the reduction of HAMD score following rTMS.
These findings suggest that the function of the prefrontal cortex in depressed patients was impaired and could be recovered by 2 Hz rTMS. The fNIRS-measured prefrontal activation during a cognitive task is a potential biomarker for monitoring depressed patients' treatment response to rTMS.
先前的研究已经表明2赫兹重复经颅磁刺激(rTMS)对抑郁症的临床疗效;然而,其潜在的神经机制仍知之甚少。本研究的目的是使用功能近红外光谱技术(fNIRS)来检测rTMS对抑郁症患者前额叶皮质活动的影响。
本研究纳入了40例重度抑郁症(MDD)患者和40名健康对照者。患者接受了为期4周的2赫兹经颅磁刺激,刺激部位为右侧背外侧前额叶皮质(DLPFC)。在rTMS治疗前后,使用fNIRS测量抑郁症患者在言语流畅性任务(VFT)期间前额叶皮质中氧合血红蛋白([oxy-Hb])浓度的变化。使用汉密尔顿抑郁量表24项版(HAMD-24)评估抑郁的严重程度。
在rTMS治疗前,与健康对照者相比,抑郁症患者在VFT期间双侧前额叶皮质中的[oxy-Hb]值显著更小。在接受4周的右侧DLPFC 2赫兹rTMS治疗后,观察到抑郁症患者在VFT期间双侧额极前额叶皮质(FPPFC)、腹外侧前额叶皮质(VLPFC)和左侧DLPFC中的[oxy-Hb]值增加。抑郁症患者右侧VLPFC中从基线到治疗后的[oxy-Hb]值增加与rTMS治疗后HAMD评分的降低呈正相关。
这些发现表明抑郁症患者前额叶皮质的功能受损,并且可以通过2赫兹rTMS恢复。在认知任务期间fNIRS测量的前额叶激活是监测抑郁症患者对rTMS治疗反应的潜在生物标志物。